Endo Pharm Reiterated at Hold and 3 Reiterated Ratings to Note

November 06, 2012

Wall St. Watchdog reveals information about companies for which stock analysts reiterated their ratings on November 6th.

National Retail Properties (NYSE:NNN): RBC Capital Mkts reiterated its rating of Outperform for this company and changed its price target from $33 to $35.

Rigel Pharms (NASDAQ:RIGL): Oppenheimer reiterated its rating of Outperform for this company and changed its price target from $12 to $15.

Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.

Cypress Sharpridge Investments (NYSE:CYS): FBR Capital reiterated its rating of Mkt Perform for this company and changed its price target from $15 to $14.

Endo Pharm (NASDAQ:ENDP): Cantor Fitzgerald reiterated its rating of Hold for this company and changed its price target from $31 to $28.

Don’t Miss: Did the Roof Just Cave in on Zillow?

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com